Enhanced solid plasma matrix as well as preparation method and application thereof

By sonicating the solid plasma matrix, the coagulation cascade is activated and the formation of a more solid fibrin network is solved, and the problems of fast degradation and insufficient strength of solid plasma matrix are significantly improved, which is significantly improved its biological activity and therapeutic effect.

CN119075008AInactive Publication Date: 2024-12-06HUBEI PRIME SHIELD BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411290557.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-14
Publication Date
2024-12-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The solid plasma matrix degrades faster and has low intensity, which limits its biological activity and tissue regeneration promotion ability.

Method used

By sonicating the centrifuged solid plasma matrix, the coagulation cascade is activated to form a more solid three-dimensional fibrin network structure, which improves mechanical strength and prolongs the release time of growth factors.

Benefits of technology

It significantly improves the mechanical strength and biological activity of solid plasma matrix, extends the degradation time, and improves the healing effect of soft and hard tissues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119075008A_ABST
    Figure CN119075008A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of blood products, in particular to an enhanced solid plasma matrix and a preparation method and application thereof. The solid plasma matrix is subjected to ultrasonic treatment, the biological activity of the solid plasma matrix is promoted by utilizing energy transmitted by ultrasound, the mechanical strength of the solid plasma matrix is improved, the degradation speed is reduced, and the wound healing capability can be promoted and a more ideal treatment effect can be obtained when the solid plasma matrix is applied to soft and hard tissue defects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of blood products, and in particular to a reinforced solid plasma matrix and a preparation method and application thereof. Background Art

[0002] With the continuous development of biomedicine and materials science, substitute plasma matrices taken from patients' own blood have received widespread attention. Among them, solid plasma matrices have autologous living cells, growth factors, three-dimensional fibrin scaffolds, etc., which can promote tissue regeneration, and are simple to prepare without rejection reactions. They have developed rapidly in recent years and are widely used in the fields of soft and hard tissue regeneration, refractory wound healing, and osteoarthritis treatment. However, solid plasma matrices have the problems of rapid degradation and low strength, which limits their biological activity and ability to promote tissue regeneration to a certain extent. Therefore, it is of practical significance to find a method to improve the strength of solid plasma matrices, prolong the degradation time of solid plasma matrices, and thus enhance biological activity and improve therapeutic effects. Summary of the invention

[0003] In order to solve the above technical problems, the present invention provides a reinforced solid plasma matrix and its preparation method and application. The present invention improves the mechanical strength of the solid plasma matrix, reduces the degradation rate, and improves the biological activity by ultrasonically treating the centrifuged solid plasma matrix, which can well solve the current problems of insufficient plasma matrix strength, fast degradation rate, insufficient biological activity, etc., and achieve a more ideal therapeutic effect.

[0004] In a first aspect, the present invention provides a method for preparing a reinforced solid plasma matrix, comprising the following steps:

[0005] (1) collecting a whole blood sample in a blood collection tube and centrifuging it;

[0006] (2) separating and collecting the solid plasma matrix in the upper layer;

[0007] (3) Ultrasonic treatment is performed on the solid plasma matrix to obtain a reinforced solid plasma matrix.

[0008] The present invention utilizes the energy transfer effect of ultrasound to more efficiently activate the coagulation cascade reaction in the plasma matrix, effectively accelerate the coagulation of plasma matrix products, promote the formation of a three-dimensional fibrin network structure inside the plasma matrix, improve the mechanical strength of the solid plasma matrix, reduce the degradation rate, and allow more platelets, leukocytes and growth factors to be encapsulated in the solid platelet-rich fibrin network structure, thereby prolonging the release time of the growth factors therein, thereby improving the biological activity of the plasma matrix products after ultrasound treatment and more effectively being used for oral soft and hard tissue repair.

[0009] In some embodiments of the present invention, the centrifugal acceleration is 60-1000g, for example, 100g, 200g, 300g, 400g, 500g, 600g, 700g, 800g, 900g, etc.

[0010] In some embodiments of the present invention, the centrifugation time is 2-10 min, for example, 3 min, 4 min, 5 min, 6 min, 7 min, 8 min, 9 min, etc.

[0011] The present invention uses a plasma matrix preparation platform to process whole blood samples, preferably a horizontal centrifugation method. After centrifugation, the whole blood is divided into three layers, including an upper pale yellow plasma matrix layer, a middle brown-yellow layer and a lower red blood cell layer.

[0012] In some embodiments of the present invention, before step (3), the solid plasma matrix is ​​further cut into pieces, pressed into films or made into thrombi.

[0013] In some embodiments of the present invention, the preparation method further comprises: before step (3), adding biological material to the solid plasma matrix.

[0014] In some embodiments of the present invention, the biomaterial includes: one or more of autologous bone chips, allogeneic bone, xenogeneic bone and artificial bone repair material.

[0015] In some embodiments of the present invention, the frequency of the ultrasonic treatment is 20-25 kHz, such as 21 kHz, 22 kHz, 23 kHz, 24 kHz, etc.

[0016] In some embodiments of the present invention, the power of the ultrasonic treatment is 20-1000 W, for example, 50 W, 100 W, 300 W, 500 W, 700 W, 900 W, etc.

[0017] In some embodiments of the present invention, the ultrasonic treatment time is 5s-20min, for example, 10s, 15s, 20s, 30s, 45s, 50s, 1min, 2min, 3min, 5min, 8min, 10min, 12min, 15min, 18min or 20min, etc.

[0018] In a second aspect, the present invention provides a reinforced solid plasma matrix, which is prepared by the preparation method described in the first aspect.

[0019] In a third aspect, the present invention provides a use of the reinforced solid plasma matrix described in the second aspect in a material for treating soft and hard tissue defects.

[0020] The reinforced solid plasma matrix of the present invention can be used directly to treat soft and hard tissue defects according to clinical needs; or it can be mixed with bone defect materials, collagen membranes, etc. and then used to treat soft and hard tissue defects. For example, the solid plasma matrix prepared by the present invention is used in gum soft tissue augmentation to better maintain the mucosal contour; it is used in gingival papilla reconstruction to resist the negative impact of complex oral chewing movements on the reconstruction area; it is used in bone augmentation areas to provide stronger mechanical protection.

[0021] In the present invention, the solid plasma matrix can be ultrasonically treated first, and the reinforced solid plasma matrix can be implanted into the soft and hard tissue defect site after preparation. The solid plasma matrix can also be implanted into the soft and hard tissue defect and then the implantation area is ultrasonically treated to form a reinforced solid plasma matrix. The application of ultrasonic treatment before implantation can enhance the cross-linking degree of the plasma matrix and improve the biological activity. The application of ultrasonic treatment to the implantation area after implantation can promote the release of active factors, and ultimately improve the tissue healing effect.

[0022] The technical solution provided by the embodiment of the present invention has the following advantages compared with the prior art:

[0023] 1. The preparation method provided by the present invention can activate platelets through the energy transmitted by ultrasound, promote the cross-linking of fibrin, and prepare a larger and more solid fibrin matrix network, so that more platelets, leukocytes and growth factors are encapsulated in the platelet-rich fibrin network in the solid plasma matrix, thereby prolonging the release time of the growth factors therein and promoting their biological activity;

[0024] 2. When the reinforced solid plasma matrix prepared by the preparation method of the present invention is used as a material for treating soft and hard tissue defects, it can effectively accelerate the coagulation of plasma matrix products, improve the mechanical strength of the solid plasma matrix, prolong the degradation time, promote soft tissue healing, and obtain a more ideal therapeutic effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the invention and, together with the description, serve to explain the principles of the invention.

[0026] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0027] Figure 1 This is a graph showing the change in mechanical strength of the solid plasma matrix before and after ultrasonic treatment;

[0028] Figure 2This is the difference diagram of the degradation time of solid plasma matrix before and after ultrasonic treatment;

[0029] Figure 3 The figure shows the change in soft tissue wound width before and after ultrasonic treatment. DETAILED DESCRIPTION

[0030] In order to more clearly understand the above-mentioned objectives, features and advantages of the present invention, the scheme of the present invention will be further described below. It should be noted that the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

[0031] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention may also be implemented in other ways different from those described herein; it is obvious that the embodiments in the specification are only part of the embodiments of the present invention, rather than all of the embodiments.

[0032] Example 1

[0033] This embodiment provides a method for preparing a reinforced solid plasma matrix, the steps are as follows:

[0034] (1) 10 mL of blood was collected from the antecubital fossa of 6 volunteers using a hydrophilic inner wall blood collection tube and quickly placed in a horizontal centrifuge for centrifugation at 700 g for 8 minutes;

[0035] (2) using the forceps in the plasma matrix preparation kit to collect and separate the upper solid plasma matrix after centrifugation;

[0036] (3) using a special solid plasma matrix membrane pressing device box to press the solid plasma matrix into a membrane;

[0037] (4) The solid plasma matrix membrane was ultrasonically treated for 30 seconds at a frequency of 25 kHz and a power of 500 W to obtain a reinforced solid plasma matrix.

[0038] Example 2

[0039] This embodiment provides a method for preparing a reinforced solid plasma matrix, the steps are as follows:

[0040] (1) 10 mL of blood was collected from the antecubital fossa of 6 volunteers using a hydrophilic inner wall blood collection tube and quickly placed in a horizontal centrifuge and centrifuged at 1000 g for 2 minutes;

[0041] (2) using the forceps in the plasma matrix preparation kit to collect and separate the upper solid plasma matrix after centrifugation;

[0042] (3) using a special solid plasma matrix membrane pressing device box to press the solid plasma matrix into a membrane;

[0043] (4) The solid plasma matrix membrane was ultrasonically treated for 5 seconds at a frequency of 20 kHz and a power of 1000 W to obtain a reinforced solid plasma matrix.

[0044] Example 3

[0045] This embodiment provides a method for preparing a reinforced solid plasma matrix, the steps are as follows:

[0046] (1) 10 mL of blood was collected from the antecubital fossa of 6 volunteers using a hydrophilic inner wall blood collection tube and quickly placed in a horizontal centrifuge and centrifuged at 60 g for 10 minutes;

[0047] (2) using the forceps in the plasma matrix preparation kit to collect and separate the upper solid plasma matrix after centrifugation;

[0048] (3) using a special solid plasma matrix membrane pressing device box to press the solid plasma matrix into a membrane;

[0049] (4) The solid plasma matrix membrane was ultrasonically treated for 20 minutes at a frequency of 22 kHz and a power of 20 W to obtain a reinforced solid plasma matrix.

[0050] Comparative Example 1

[0051] This embodiment provides a method for preparing a solid plasma matrix, which differs from Embodiment 1 in that step (4) is not included.

[0052] Performance Testing

[0053] 1. Mechanical strength

[0054] The maximum tensile force of the reinforced solid plasma matrix prepared in Example 1 and the solid plasma matrix prepared in Comparative Example 1 was measured using a tensile tester. The results are as follows: Figure 1 shown.

[0055] Depend on Figure 1 It can be seen that the breaking strength of the solid plasma matrix after ultrasonic treatment is significantly increased compared with the solid plasma matrix without ultrasonic treatment, indicating that the solid plasma matrix after ultrasonic treatment can better resist the stretching and tearing of the membrane caused by external mechanical stress.

[0056] 2. Degradation time

[0057] The fortified solid plasma matrix prepared in Example 1 and the solid plasma matrix prepared in Comparative Example 1 were placed in sterile 1×PBS (pH neutral) and stored at 37°C. The end point of degradation was when the plasma matrix had no intact form. The degradation time was recorded. The results are shown in FIG. Figure 2 shown.

[0058] Depend on Figure 2It can be seen that the volume maintenance time of the solid plasma matrix after ultrasonic treatment is significantly improved and the degradation time is significantly prolonged compared with the solid plasma matrix without ultrasonic treatment.

[0059] 3. Soft tissue healing

[0060] When performing human oral keratinized gingival transplantation, the soft tissue of the upper palate was obtained, and then the reinforced solid plasma matrix prepared in Example 1 and the solid plasma matrix prepared in Comparative Example 1 were respectively applied to the wound of the upper palate, covered with iodoform gauze, and sutured and fixed. At the same time, a blank control group (no substance was implanted in the wound) was set up, and the width of the soft tissue wound was recorded 3 days after the operation. The results are as follows: Figure 3 shown.

[0061] Depend on Figure 3 It can be seen that the solid plasma matrix after ultrasound treatment can significantly accelerate the healing of soft tissue wounds compared with the solid plasma matrix without ultrasound treatment.

[0062] In summary, the enhanced solid plasma matrix preparation method provided by the present invention can significantly improve the mechanical strength of the solid plasma matrix, prolong its degradation time, improve its biological activity, and obtain a more ideal therapeutic effect.

[0063] It should be noted that, in this article, relational terms such as "first" and "second" are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, the elements defined by the sentence "comprise a ..." do not exclude the existence of other identical elements in the process, method, article or device including the elements.

[0064] The above description is only a specific embodiment of the present invention, so that those skilled in the art can understand or implement the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments described herein, but should conform to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A method for preparing a reinforced solid plasma matrix, characterized in that: The steps include: (1) collecting a whole blood sample in a blood collection tube and centrifuging it; (2) separating and collecting the solid plasma matrix in the upper layer; (3) Ultrasonic treatment is performed on the solid plasma matrix to obtain a reinforced solid plasma matrix.

2. The preparation method according to claim 1, characterized in that: The centrifugal acceleration is 60-1000g.

3. The preparation method according to claim 1 or 2, characterized in that: The centrifugation time is 2-10 min.

4. The preparation method according to any one of claims 1 to 3, characterized in that: The preparation method further comprises: before step (3), cutting the solid plasma matrix into pieces, pressing films or making thrombi.

5. The preparation method according to any one of claims 1 to 4, characterized in that: The preparation method further comprises: before step (3), adding biological material to the solid plasma matrix; Preferably, the biomaterial comprises: one or more of autologous bone chips, allogeneic bone, xenogeneic bone and artificial bone repair material.

6. The preparation method according to any one of claims 1 to 5, characterized in that: The frequency of the ultrasonic treatment is 20-25 kHz.

7. The preparation method according to any one of claims 1 to 6, characterized in that: The power of the ultrasonic treatment is 20-1000W.

8. The preparation method according to any one of claims 1 to 7, characterized in that: The ultrasonic treatment time is 5s-20min.

9. A fortified solid plasma matrix, characterized in that The reinforced solid plasma matrix is ​​prepared by the preparation method according to any one of claims 1-8.

10. Use of the reinforced solid plasma matrix according to claim 9 in materials for treating soft and hard tissue defects.